ANTICUERPOS ANTI-Β2-GLICOPROTEÍNA 1 IGG/IGM. - COFEPRIS Registration 1646R2019 SSA
Access comprehensive regulatory information for ANTICUERPOS ANTI-Β2-GLICOPROTEÍNA 1 IGG/IGM. (ANTI-Β2-GLYCOPROTEIN 1 IGG/IGM ANTIBODIES.) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1646R2019 SSA and manufactured by BIO SIMEX, S.A. DE C.V.. The device was registered on August 16, 2019.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
REACTIVOS PARA LA DETERMINACIÓN CUALITATIVA Y CUANTITATIVA DE ANTICUERPOS ANTI-Β2-GLICOPROTEÍNA 1 EN SUERO O PLASMA HUMANO. AGENTE DE DIAGNÓSTICO IN VITRO PARA USO EXCLUSIVO EN LABORATORIOS CLÍNICOS O DE GABINETES.
REAGENTS FOR THE QUALITATIVE AND QUANTITATIVE DETERMINATION OF ANTI-Β2-GLICOPROTEIN 1 ANTIBODIES IN HUMAN SERUM OR PLASMA. IN VITRO DIAGNOSTIC AGENT FOR USE IN CLINICAL OR CABINET LABORATORIES ONLY.